Form 4 for RZLT Rezolute, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-16 · accession 0000912282-25-000173 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-16 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | A - Grant | $0.00 | +77.0K | 131.4K | +142% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-16 | A | A | 77,000 | $0.00 | 131,352 | D | — | — | (F1) Represents grant of restricted stock units which vest as follows: 1/3 on March 1, 2026; 1/3 on March 1, 2027; and 1/3 on March 1, 2028. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-16 | A | A | 45,000 | $0.00 | 45,000 | D | $4.61 · — to 2035-02-16 | 45,000 Common Shares | (F2) The options vest as follows: 1/36th monthly beginning on March 16, 2025. |